Skip to main contentSkip to navigation
Sirius Investors

BTX Stock: BlackRock Technology and Private Equity Term Trust Stock Price, Analysis & Insights

Get live BTX stock price $8.72, comprehensive BlackRock Technology and Private Equity Term Trust stock analysis, charts, news, and expert forecast. Real-time BTX stock data and investment insights.

8.72
1.52%Today
BTXBlackRock Technology and Private Equity Term Trust • New York Stock Exchange • Healthcare
Market Cap
1.02B
Volume
580.11K
52W High
9.38
52W Low
6.13

Loading chart data...

BlackRock Technology and Private Equity Term Trust (BTX) Overview

BlackRock Technology and Private Equity Term Trust (BTX) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, BTX trades at $8.72 with a market capitalization of 1.02B . Over the past 52 weeks, BTX has traded between $6.13 and $9.38 , with the current price positioned at approximately 80% of this range . The s...

Key Takeaways

  • Operates in the Healthcare sector (Biotechnology)
  • Market cap: 1.02B
  • Current price: $8.72
  • 52-week range: $6.13 - $9.38
  • P/E ratio: 23.58

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

The BlackRock Innovation and Growth Trust, a newly organized and non-diversified closed-end investment management company, currently possesses no operating history. Its primary goals are to generate total return and income, which it aims to achieve t...

Company Information

CEO
John M. Perlowski
Sector
Healthcare
Industry
Biotechnology
Employees
N/A

Contact Information

Address
10355 Science Center Drive
Country
US

Investment Analysis & Business Insights

Healthcare
Biotechnology

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 23.6)

Higher growth potential with elevated volatility (Beta: 1.37)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for BlackRock Technology and Private Equity Term Trust shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for BlackRock Technology and Private Equity Term Trust
  • Investors should consider how BlackRock Technology and Private Equity Term Trust fits within their overall portfolio allocation

Market Cap

1.02B

P/E Ratio (TTM)

23.58

Beta

1.37

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.